Marvell Technology Shares Climb on AI Chip Demand Optimism China Coal Mine Incident Highlights Challenges to Energy Security Strategy Under Xi Jinping SpaceX and OpenAI Potential IPOs Could Eclipse Berkshire Hathaways Market Cap on Debut SP 500 Edges Higher Led by Healthcare and Tech Communication Services Lags Googles Homepage Redesign A Small Visual Change With Big Strategic Implications Former BP Chairman Hits Back at Anonymous Critics Defends Tenure Amid Allegations SuperCom SPCB Q4 2025 Earnings Massive EPS Beat Surprises Market MarineMax Inc HZO Q1 2026 Earnings EPS Falls Short of Expectations Amid Challenging Environment SGML Q1 2026 Earnings EPS Surges Past Estimates Shares Rise 282 Oxford Industries OXM Q1 2026 Earnings Significant EPS Miss but Shares Rally COLB Q1 2026 Earnings EPS Surpasses Expectations with 30 Beat CLLS Q1 2026 Earnings NarrowerThanExpected Loss as GeneEditing Pipeline Advances Charlton Aria Acquisition Rights CHARR Plunge 3289 to 008 as Selling Pressure Intensifies Kezar Life Sciences KZR Stays Flat Key Levels and Technical Outlook New Providence Acquisition Corp III Warrants NPACW Edges Higher as Warrants Test Key Resistance Galata Acquisition Corp II Warrants Hold Steady at 030 as Key Levels Remain Defined Inventiva IVA Slips 27 as Shares Test Key Support Levels Gaza Flotilla Detainee Allegations Could Impact Israels International Relations and Economic Stability CBUS Q1 2026 Earnings Narrowing Losses Surpass Expectations as Operational Progress Continues Crescent Biopharma CBIO Surges 459 as Biotech Sector Gains Momentum Voyager Acquisition Corp VACH Faces Steep Decline Testing Support Levels After 654 Drop OFS Credit Company Inc OCCI Edges Higher Navigating Support and Resistance Levels Silicon Valley Acquisition Corp SVAQ Holds Steady at 995 Consolidation in the SPAC Sector PharmaCyte Biotech PMCB Edges Higher SupportHolding Action at 081 Seres Therapeutics MCRB Declines 593 as Selling Pressure Intensifies Gorilla Technology Group Inc GRRR Capitalizes on Recent Momentum Approaches Key Resistance Drugs Made In America Acquisition Corp DMAA Holds Steady at 1060 SPAC Stabilization in Focus